Jan Kaiserle

The medical landscape has been witnessing a groundbreaking shift with the advent of novel therapies aimed at tackling some of the most challenging conditions. One such development is the Phase 1/2 clinical trial of Cabaletta Bio's CAR T-cell therapy, rese-cel (resecabtagene autoleucel),

The University of South Florida (USF) is undertaking significant expansions in its biomedical engineering program to address its consistent and rapid growth. Established in 2017 with just a single faculty member and courses tailored exclusively for graduate students, the program has seen remarkable

Epic Medical, headquartered in Singapore, is poised to significantly impact Pekin, Illinois, by investing $25 million in a new medical equipment manufacturing facility. Announced during a well-attended news conference in the Pekin City Council meeting room, the agreement was formalized by Mayor

Farmers in Dorset have been advised to reinforce their biosecurity measures following the detection of the avian influenza virus, specifically the H5N1 strain, in a sheep in Yorkshire. The occurrence of this virus in a sheep for the first time serves as a crucial reminder for farms, particularly

Technology and science are constantly evolving and advancing, and with them, the world of drug development is also changing. Using AI and CRISPR for gene editing and bioprinting human-like tissues are just some examples of innovations that are set to change how life-saving therapies are developed.

In a groundbreaking initiative aimed at transforming the health regulatory landscape across the African continent, the first African Regulators Leadership Program (ARLP) was convened at the Wits Business School in Johannesburg. This program is designed to elevate the leadership skills and

The utilization of machine learning to predict nonadherence to antiretroviral treatment (ART) among adolescents in Uganda has unveiled promising solutions. Claire Najjuuko, a doctoral student at Washington University in St. Louis, has led a groundbreaking research initiative aiming to improve ART

A groundbreaking breakthrough by researchers at the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart has led to the transformation of single-cell green microalgae into magnetically controlled microrobots, showcasing exciting potential for the future of targeted drug delivery in

In a surprising move, Sutro Biopharma has decided to undertake a sweeping restructuring plan with the primary goal of conserving capital, leading to a nearly 50% reduction in its workforce, the ousting of CEO Bill Newell, the discontinuation of its lead drug candidate luveltamab tazevibulin

Pancreatic cancer, recognized for its aggressive nature and limited treatment options, remains one of the most challenging malignancies to manage. Researchers at the Perelman School of Medicine, University of Pennsylvania, and Penn Medicine's Abramson Cancer Center have recently unveiled